PLATFORM & PIPELINE
Based on good will, we continuously strive to innovate science
and technology to improve the quality of life of patients and their families.
CONFERENCE
- AD/PD 2026
- Oral Presentation (Sanghoon Park), 19 March / Copenhagen, Denmark
- A GAS6-Based Fusion Protein (GAIA) Enabling Inflammation-Silent Clearance of Amyloid Beta and Mitigation of ARIA Risk in Alzheimer’s Disease
- AAIC 2025
- Oral Presentation (Jinkyung Lee), 28 July / Toronto, Canada
- Efferocytosis-Driven Reduction of Neuroinflammation and Amyloid Beta Burden via Novel GAS6 Fusion Protein (GAIA): A Promising Therapeutic Approach in Alzheimer's Disease
- Keystone 2025 (Neurodegeneration / Neural-Immune Interactions)
- Poster Presentation, 9 June / Whistler, Canada
- Efferocytosis-Driven Neuroinflammation Reduction by Novel GAS6 Fusion Protein (GAIA) in Anti-Aβ immunotherapies
- PEGS Boston 2025
- Poster Presentation, 13 May / Boston, USA
- Therapeutic Potential of Novel GAS6-Mediated Anti-Inflammatory Adaptor (GAIA): Overcoming Neuroinflammation via Efferocytosis in Anti-Aβ Immunotherapies
- AD/PD 2025
- Poster Presentation, 2~3 April / Vienna, Austria
- Efferocytosis-Driven Neuroinflammation Reduction by Novel GAS6 Fusion Protein (GAIA) in Anti-Aβ immunotherapies
- CTAD 2024
- Poster Presentation, 31 October / Madrid, Spain
- Therapeutic potential of novel GAS6 fusion protein (GAIA): Overcoming neuroinflammation via efferocytosis in anti-Aβ immunotherapies
- Keystone 2024 (Neurodegenerative Diseases / Neuroimmune Interactions)
- Poster Presentation, 4 June / Santa Fe, USA
- Anti-inflammatory clearance of amyloid-β (Aβ) by a chimeric GAS6 fusion protein and application for neurodegenerative diseases
- PEGS Boston 2024
- Poster Presentation, 13 May / Boston, USA
- Anti-inflammatory clearance of Aβ by a chimeric GAS6 fusion protein
- CTAD 2023
- Poster Presentation, 24~27 October / Boston, USA
- New Approaches to Alzheimer’s Disease – Novel Chimeric GAS6 Fusion Protein
- AAIC 2023
- Poster Presentation, 16 July / Amsterdam, Netherland
- Anti-inflammatory clearance of amyloid beta by a chimeric GAS6 fusion protein
- Cerebral Vascular Biology (CVB) 2023
- Oral Presentation (Wonsuk Chung), 20 June / Uppsala, Sweden
- Anti-inflammatory clearance of amyloid beta by a chimeric GAS6 fusion protein
- Keystone 2023 (Neuroimmune Interactions / Neurodegeneration)
- Poster Presentation, 17~18 June / Whistler, Canada
- Anti-inflammatory clearance of Aβ by a chimeric GAS6 fusion protein
- The 7th Venusberg Meeting on Neuroinflammation 2023
- Oral Presentation (Chanhyuk Kim), 11 May / Luxembourg, Luxembourg
- Anti-inflammatory clearance of amyloid beta by a novel chimeric phagocytosis induce
- The 11th Genome Drug Discovery & Emergence Forum 2022
- Oral Presentation (Wonsuk Chung), 22 November / Online, Japan
- Anti-inflammatory clearance of amyloid beta by a chimeric GAS6 fusion protein
- Bio Korea 2022
- Oral Presentation (Wonsuk Chung), 12 May / Seoul, Republic of Korea
- Anti-inflammatory clearance of amyloid beta by a novel chimeric phagocytosis inducer
- Keystone 2022 (Neuro-Immune Interactions in the CNS / Neurodegeneration)
- Oral Presentation (Hyeonchul Jung), 9 June / Keystone, USA
- Anti-inflammatory Clearance of Amyloid Beta by a Chimeric GAS6 Fusion Protein
- AD/PD 2022
- Oral Presentation (Wonsuk Chung), 17 March / Barcelona, Spain
- Anti-inflammatory Clearance of Amyloid Beta by a Chimeric GAS6 Fusion Protein